Investment Partners Asset Management’s GSK GSK Stock Holding History

Investment Partners Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,564	Closed	-$252K	–	175
2026 Q1	$252K	Sell	4,564 -7,485	-62%	-$406K	0.16%	145
2025 Q4	$591K	Sell	12,049 -2,082	-15%	-$97.1K	0.37%	77
2025 Q3	$610K	Buy	14,131 +335	+2%	+$13.1K	0.4%	72
2025 Q2	$530K	Sell	13,796 -2,262	-14%	-$86.4K	0.37%	81
2025 Q1	$622K	Sell	16,058 -744	-4%	-$27.2K	0.49%	65
2024 Q4	$568K	Buy	16,802 +1,243	+8%	+$44.7K	0.45%	68
2024 Q3	$636K	Buy	15,559 +344	+2%	+$14.1K	0.52%	59
2024 Q2	$586K	Buy	15,215 +255	+2%	+$10.7K	0.52%	58
2024 Q1	$641K	Hold	14,960	–	–	0.58%	52
2023 Q4	$554K	Buy	+14,960	New	+$537K	0.55%	58

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Investment Partners Asset Management's GSK Position: Q2 2026 in Review

Investment Partners Asset Management sold out of GSK (GSK) in Q2 2026, closing a stake of 4,564 shares — an estimated $252K sold.

Investment Partners Asset Management first reported a position in GSK in Q4 2023 and held it in 10 quarters. The position peaked at $641K in Q1 2024. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Investment Partners Asset Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Investment Partners Asset Management sold 4,564 GSK shares in Q2 2026, an estimated $252K.
Investment Partners Asset Management first reported a position in GSK in Q4 2023 and held it in 10 quarters.
Investment Partners Asset Management's GSK position peaked at $641K in Q1 2024.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.